JP7214755B2 - 医薬品活性成分に適した錠剤化チューインガム - Google Patents

医薬品活性成分に適した錠剤化チューインガム Download PDF

Info

Publication number
JP7214755B2
JP7214755B2 JP2020564437A JP2020564437A JP7214755B2 JP 7214755 B2 JP7214755 B2 JP 7214755B2 JP 2020564437 A JP2020564437 A JP 2020564437A JP 2020564437 A JP2020564437 A JP 2020564437A JP 7214755 B2 JP7214755 B2 JP 7214755B2
Authority
JP
Japan
Prior art keywords
chewing gum
particles
sugar alcohol
tableted chewing
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020564437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021524442A (ja
JP2021524442A5 (cg-RX-API-DMAC10.html
Inventor
ヘレ・ウィトルフ
Original Assignee
フェルティン ファルマ アー/エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/982,772 external-priority patent/US11096895B2/en
Priority claimed from US15/986,362 external-priority patent/US11090263B2/en
Application filed by フェルティン ファルマ アー/エス filed Critical フェルティン ファルマ アー/エス
Publication of JP2021524442A publication Critical patent/JP2021524442A/ja
Publication of JP2021524442A5 publication Critical patent/JP2021524442A5/ja
Application granted granted Critical
Publication of JP7214755B2 publication Critical patent/JP7214755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/08—Chewing gum characterised by the composition containing organic or inorganic compounds of the chewing gum base
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/10—Chewing gum characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0204—Specific forms not provided for by any of groups A61K8/0208 - A61K8/14
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8188—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bonds, and at least one being terminated by a bond to sulfur or by a hertocyclic ring containing sulfur; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
JP2020564437A 2018-05-17 2019-05-15 医薬品活性成分に適した錠剤化チューインガム Active JP7214755B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15/982,772 2018-05-17
US15/982,772 US11096895B2 (en) 2018-05-17 2018-05-17 Oral tablet suitable for active pharmaceutical ingredients
US15/986,362 US11090263B2 (en) 2018-05-22 2018-05-22 Tableted chewing gum suitable for active pharmaceutical ingredients
US15/986,362 2018-05-22
PCT/DK2019/050157 WO2019219147A1 (en) 2018-05-17 2019-05-15 A tableted chewing gum suitable for active pharmaceutical ingredients

Publications (3)

Publication Number Publication Date
JP2021524442A JP2021524442A (ja) 2021-09-13
JP2021524442A5 JP2021524442A5 (cg-RX-API-DMAC10.html) 2021-10-21
JP7214755B2 true JP7214755B2 (ja) 2023-01-30

Family

ID=66820994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020564437A Active JP7214755B2 (ja) 2018-05-17 2019-05-15 医薬品活性成分に適した錠剤化チューインガム

Country Status (11)

Country Link
EP (1) EP3787604B1 (cg-RX-API-DMAC10.html)
JP (1) JP7214755B2 (cg-RX-API-DMAC10.html)
KR (1) KR102697867B1 (cg-RX-API-DMAC10.html)
CN (1) CN112118831B (cg-RX-API-DMAC10.html)
AU (1) AU2019268497B2 (cg-RX-API-DMAC10.html)
BR (1) BR112020022379A2 (cg-RX-API-DMAC10.html)
CA (1) CA3097953C (cg-RX-API-DMAC10.html)
ES (1) ES2951848T3 (cg-RX-API-DMAC10.html)
MX (1) MX2020012265A (cg-RX-API-DMAC10.html)
RU (1) RU2770035C1 (cg-RX-API-DMAC10.html)
WO (1) WO2019219147A1 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096894B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US11471405B2 (en) 2019-03-01 2022-10-18 Nordiccan A/S Tableted chewing gum with enhanced delivery of cannabinoids
US11253473B2 (en) 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
CA3159297A1 (en) * 2019-12-09 2021-06-17 Jr. Darrell Eugene Holton Oral products with controlled release
AU2021268062B2 (en) * 2020-05-08 2024-08-15 Fertin Pharma A/S Flowpack for oral delivery of active ingredients
US12382982B2 (en) 2021-06-25 2025-08-12 Nicoventures Trading Limited Oral products and method of manufacture
DK202330231A1 (en) * 2023-09-27 2025-04-10 Fertin Pharma As Cannabidiol for alleviating xerostomia
US20250268831A1 (en) * 2024-02-25 2025-08-28 Alexia C. Harvey Compact compositions comprising zingiberaceae rhizomes for active and additive applications and manufacturing method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001524956A (ja) 1997-04-16 2001-12-04 シーマ・ラブス・インコーポレイテッド 迅速溶解性の頑丈な投与形態物
US20020037340A1 (en) 1999-12-30 2002-03-28 Wm. Wrigley Jr. Company. Chewing gum product including a hydrophilic gum base and method of producing
WO2006063189A2 (en) 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
WO2009080023A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising peptide
JP2011520938A (ja) 2008-05-21 2011-07-21 ノバルティス アーゲー ニコチンおよび緩衝剤を含む打錠可能なチューインガム
US20150250856A1 (en) 2014-03-04 2015-09-10 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof
JP2017522019A (ja) 2014-07-01 2017-08-10 ロケット フレールRoquette Freres 菓子製品の新規組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070510A (en) 1959-11-03 1962-12-25 Procter & Gamble Dentifrice containing resinous cleaning agents
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US3862307A (en) 1973-04-09 1975-01-21 Procter & Gamble Dentifrices containing a cationic therapeutic agent and improved silica abrasive
US4340583A (en) 1979-05-23 1982-07-20 J. M. Huber Corporation High fluoride compatibility dentifrice abrasives and compositions
US4997654A (en) * 1989-08-14 1991-03-05 Warner-Lambert Company Method for increasing salivation for xerostomia patients
TW391880B (en) * 1994-01-31 2000-06-01 Yamanouchi Pharma Co Ltd An oral soluble type compression moulding and its preparation
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
CA2435546A1 (en) * 2001-02-08 2002-08-15 Alice C. Martino Rapid-onset medicament for the treatment of sexual dysfunction
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
RU2391856C2 (ru) * 2005-12-16 2010-06-20 Вм. Ригли Дж. Компани Жевательная резинка в оболочке
ATE462416T1 (de) * 2006-08-04 2010-04-15 Ethypharm Sa Mehrschichtige im mund zerfallende tablette
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
CA2733800C (en) * 2008-08-14 2014-04-15 Wm. Wrigley Jr. Company Confectionery products providing an increased hydration sensation
WO2013091631A1 (en) * 2011-12-22 2013-06-27 Fertin Pharma A/S Method of releasing nicotine from chewing gum
WO2013171164A1 (en) * 2012-05-14 2013-11-21 EJP Pharmaceutical ApS Compositions and formulations for the treatment of halitosis
JP6840849B2 (ja) * 2016-11-18 2021-03-10 フェルティン ファルマ アー/エス 別個の結合剤及びエリスリトールを含む錠剤
EP3854383A1 (en) * 2016-11-18 2021-07-28 Fertin Pharma A/S Oral delivery vehicle

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001524956A (ja) 1997-04-16 2001-12-04 シーマ・ラブス・インコーポレイテッド 迅速溶解性の頑丈な投与形態物
US20020037340A1 (en) 1999-12-30 2002-03-28 Wm. Wrigley Jr. Company. Chewing gum product including a hydrophilic gum base and method of producing
WO2006063189A2 (en) 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
WO2009080023A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising peptide
JP2011520938A (ja) 2008-05-21 2011-07-21 ノバルティス アーゲー ニコチンおよび緩衝剤を含む打錠可能なチューインガム
US20150250856A1 (en) 2014-03-04 2015-09-10 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof
JP2017522019A (ja) 2014-07-01 2017-08-10 ロケット フレールRoquette Freres 菓子製品の新規組成物

Also Published As

Publication number Publication date
AU2019268497B2 (en) 2022-01-06
CA3097953A1 (en) 2019-11-21
WO2019219147A1 (en) 2019-11-21
KR102697867B1 (ko) 2024-08-23
CN112118831B (zh) 2023-04-21
AU2019268497A1 (en) 2020-10-22
ES2951848T3 (es) 2023-10-25
EP3787604C0 (en) 2023-07-05
RU2770035C1 (ru) 2022-04-14
JP2021524442A (ja) 2021-09-13
MX2020012265A (es) 2021-01-29
EP3787604A1 (en) 2021-03-10
BR112020022379A2 (pt) 2021-02-02
EP3787604B1 (en) 2023-07-05
CN112118831A (zh) 2020-12-22
CA3097953C (en) 2023-09-12
KR20210013551A (ko) 2021-02-04

Similar Documents

Publication Publication Date Title
KR102697867B1 (ko) 활성 약학적 성분에 적합한 정제형 츄잉 검
JP7475286B2 (ja) 医薬品活性成分に適した崩壊性経口錠剤
CN112153964B (zh) 包含非直接可压糖醇颗粒的适用于活性药物成分的经口片剂
WO2019219145A1 (en) An oral tablet suitable for fast release of active pharmaceutical ingredients
JP2019535821A (ja) 経口送達ビヒクル
KR102706980B1 (ko) 타액 생성을 유도하기 위한 경구용 정제
US11090263B2 (en) Tableted chewing gum suitable for active pharmaceutical ingredients
RU2782830C2 (ru) Таблетка для перорального приема для индуцированного образования слюны

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210812

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210812

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220419

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220830

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221223

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230118

R150 Certificate of patent or registration of utility model

Ref document number: 7214755

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250